KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Divestments (2016 - 2025)

Historic Divestments for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $279.0 million.

  • Bristol Myers Squibb's Divestments rose 941.18% to $279.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 1171.8%. This contributed to the annual value of $1.1 billion for FY2024, which is 2090.21% up from last year.
  • Latest data reveals that Bristol Myers Squibb reported Divestments of $279.0 million as of Q3 2025, which was up 941.18% from $270.0 million recorded in Q2 2025.
  • Bristol Myers Squibb's Divestments' 5-year high stood at $490.0 million during Q4 2022, with a 5-year trough of $178.0 million in Q4 2021.
  • For the 5-year period, Bristol Myers Squibb's Divestments averaged around $255.4 million, with its median value being $241.0 million (2023).
  • In the last 5 years, Bristol Myers Squibb's Divestments surged by 17528.09% in 2022 and then tumbled by 5081.63% in 2023.
  • Over the past 5 years, Bristol Myers Squibb's Divestments (Quarter) stood at $178.0 million in 2021, then soared by 175.28% to $490.0 million in 2022, then crashed by 50.82% to $241.0 million in 2023, then skyrocketed by 38.17% to $333.0 million in 2024, then decreased by 16.22% to $279.0 million in 2025.
  • Its Divestments was $279.0 million in Q3 2025, compared to $270.0 million in Q2 2025 and $243.0 million in Q1 2025.